-- title: "Porcine Reproductive and Respiratory Syndrome (PRRS): Genomic Surveillance and Next-Generation Vaccines" category: "livestock-viruses" metaDescription: "A detailed review of PRRSV-1 and PRRSV-2 genomic surveillance, whole-genome sequencing for variant tracking, and the efficacy of modified-live versus mRNA-based experimental vaccines." primaryKeyword: "PRRS genomic surveillance" secondaryKeywords: ["PRRSV-1", "PRRSV-2", "whole-genome sequencing", "modified-live vaccine", "mRNA vaccine", "porcine reproductive and respiratory syndrome"]

Porcine Reproductive and Respiratory Syndrome (PRRS): Genomic Surveillance and Next-Generation Vaccines

Introduction

Porcine Reproductive and Respiratory Syndrome (PRRS) remains one of the most economically impactful viral diseases affecting the global swine industry. The causative agent, PRRS virus (PRRSV), is an enveloped, positive-sense single-stranded RNA virus belonging to the family Arteriviridae, order Nidovirales. The virus is characterized by its high genetic diversity, rapid mutation rate, and propensity for recombination, which collectively complicate both diagnostic surveillance and vaccine development. This article provides a comprehensive review of the genomic surveillance strategies for PRRSV, focusing on the differentiation of PRRSV-1 and PRRSV-2 lineages, the application of whole-genome sequencing for variant tracking, and a comparative analysis of modified-live virus (MLV) vaccines versus experimental mRNA-based vaccine platforms.

Virological and Genomic Architecture of PRRSV

The PRRSV genome is approximately 15 kilobases in length and contains at least 10 open reading frames (ORFs). The replicase polyproteins pp1a and pp1ab are encoded by ORF1a and ORF1b, respectively, and are processed into at least 16 nonstructural proteins (nsps) that mediate viral replication and transcription. The structural proteins include the glycoproteins GP2a, GP2b, GP3, GP4, and GP5, the membrane protein M, and the nucleocapsid protein N. GP5 and M form the major heterodimer on the virion surface and are primary targets for neutralizing antibodies.

PRRSV is classified into two distinct species: Betaarterivirus europensis (PRRSV-1, formerly European genotype) and Betaarterivirus americense (PRRSV-2, formerly North American genotype). These two species share only approximately 60% nucleotide identity across the genome, with even greater divergence in specific regions such as ORF5 and nsp2. Within each species, multiple lineages and sublineages have been described based on phylogenetic analysis of ORF5 sequences. PRRSV-1 is further divided into subtypes 1 through 4, with subtype 1 (Lelystad-like) being the most prevalent in Europe. PRRSV-2 is classified into at least nine lineages (L1 through L9), with L1 (including the highly pathogenic MN184-like strains), L5 (including the Ingelvac-like strains), L8 (including the highly pathogenic Chinese HP-PRRSV strains), and L9 (including the NADC30-like strains) being of particular clinical significance [1, 2, 15].

Genomic Surveillance: Differentiating PRRSV-1 and PRRSV-2 Lineages

Effective genomic surveillance requires robust molecular diagnostic tools capable of differentiating between PRRSV-1 and PRRSV-2, as well as identifying emerging variants and recombinant strains. Traditional diagnostic approaches have relied on ORF5-based Sanger sequencing for genotyping. However, the increasing diversity of circulating strains, particularly the emergence of highly pathogenic L8 lineage strains of PRRSV-2, has necessitated the development of more sophisticated assays.

A locked nucleic acid (LNA) based one-step multiplex reverse transcription quantitative PCR (RT-qPCR) assay has been developed and validated for the simultaneous differentiation of PRRSV-1, PRRSV-2, and the highly pathogenic L8 lineage of PRRSV-2 [1]. This assay employs LNA-modified probes that enhance the melting temperature and specificity of hybridization, allowing for robust discrimination between closely related targets. The assay targets conserved regions within ORF7 for species-level identification and a specific region within nsp2 for L8 lineage detection. The analytical sensitivity of this multiplex assay is comparable to that of singleplex assays, with a limit of detection of approximately 10 copies per reaction for each target [1].

The genetic variability of PRRSV-2, particularly within sublineage 1A, has been extensively characterized in commercial pig populations. Analysis of ORF5 sequences from samples collected in Lima revealed a high degree of genetic diversity, with multiple N-glycosylation site polymorphisms observed in the GP5 ectodomain [2]. These N-glycosylation patterns are critical for immune evasion, as they can shield neutralizing epitopes from antibody recognition. Furthermore, recombination events between different PRRSV-2 lineages have been documented, with breakpoints frequently occurring within the nsp2 and ORF3-ORF5 regions [2, 15]. The detection of such recombinants underscores the need for whole-genome sequencing rather than single-gene typing for accurate epidemiological tracking.

Whole-Genome Sequencing for Variant Tracking

Whole-genome sequencing (WGS) provides the highest resolution for characterizing PRRSV diversity, identifying recombination events, and tracking transmission pathways. Targeted next-generation sequencing (NGS) panels have been developed for the simultaneous detection and characterization of common and emerging swine respiratory pathogens, including PRRSV [8]. These panels utilize multiplex PCR amplification of conserved genomic regions followed by high-throughput sequencing. The analytic validation of such panels has demonstrated high sensitivity (greater than 95% for PRRSV detection) and specificity, with the ability to detect co-infections and mixed viral populations [8].

The application of WGS has revealed the complex evolutionary dynamics of PRRSV in endemic settings. For example, the characterization of a Korean NADC30-like PRRSV strain (L9 lineage) associated with high fever and mortality demonstrated that this strain arose from multiple recombination events involving a NADC30-like donor and a HP-PRRSV-like donor [15]. The recombinant virus exhibited enhanced pathogenicity in vivo, with higher and prolonged viremia compared to the parental strains. This finding highlights the risk of recombination between vaccine-derived strains and field strains, a phenomenon that has been documented for MLV vaccines.

Reverse genetics approaches have been instrumental in understanding the functional consequences of specific genomic mutations. A circular polymerase extension reaction (CPER) based method has been developed for the rapid generation of recombinant arteriviruses without the need for traditional cloning steps [13]. This technique allows for the precise introduction of mutations or the construction of chimeric viruses, enabling functional studies of viral proteins and the rapid generation of vaccine candidates.

Viral Pathogenesis and Host Interactions

PRRSV exhibits a restricted tropism for cells of the monocyte/macrophage lineage, particularly porcine alveolar macrophages. The virus enters host cells via receptor-mediated endocytosis, with CD163 serving as the primary entry receptor. Following entry, the viral replicase complex is assembled on modified intracellular membranes derived from the endoplasmic reticulum. The nonstructural proteins play critical roles in modulating host antiviral responses.

NSP2, a multifunctional protein with deubiquitinating and papain-like protease activities, has been shown to hijack host lipophagy through a LIPE-PNPLA2-AMPK-MTOR axis to promote viral replication [5]. This interaction facilitates the mobilization of lipid droplets, providing energy and membrane components for viral replication complexes. NSP8 suppresses NF-kappaB signaling by hijacking host UBE2K and IKKalpha, thereby inhibiting the production of pro-inflammatory cytokines and type I interferons [6]. The heterodimerization of the replicase membrane proteins nsp2 and nsp3 regulates their cytoplasmic tail binding to the viral RNA-dependent RNA polymerase (RdRp) domain, which is essential for subgenomic RNA synthesis [10].

Host microRNAs also play a role in PRRSV pathogenesis. miR-378b-3p promotes PRRSV replication by negatively regulating type I interferon expression via targeting O-linked N-acetylglucosamine transferase (OGT) [11]. This represents a host factor that the virus exploits to evade innate immunity. Conversely, certain natural compounds have been shown to activate innate antiviral immunity. Myricetin, a flavonoid, activates the innate immune response during PRRSV infection in MARC-145 cells, leading to reduced viral replication [12].

Modified-Live Virus Vaccines: Efficacy and Limitations

Modified-live virus (MLV) vaccines are the most widely used commercial vaccines for PRRS control. These vaccines are derived from attenuated field strains that have been passaged in cell culture to reduce virulence. MLV vaccines provide partial protection against homologous challenge, reducing clinical signs and viremia. However, their efficacy against heterologous strains is variable and often suboptimal.

The primary limitation of MLV vaccines is their inability to provide broad cross-protection against the diverse circulating PRRSV strains. This is due to the high genetic and antigenic variability of the virus, particularly within the GP5 and GP3 glycoproteins, which are the major targets of neutralizing antibodies. Furthermore, MLV vaccines can revert to virulence, and vaccine-derived strains have been implicated in recombination events with field strains, leading to the emergence of novel pathogenic variants [15]. The safety concerns associated with MLV vaccines, including the potential for vertical transmission and the induction of immunosuppression, have driven the search for alternative vaccine platforms.

Next-Generation Vaccines: mRNA-Based Platforms

Messenger RNA (mRNA) based vaccines represent a promising next-generation platform for PRRS control. Unlike MLV vaccines, mRNA vaccines are non-infectious and cannot revert to virulence. They are also highly adaptable, allowing for the rapid incorporation of sequences from emerging variants. The mRNA platform involves the in vitro transcription of a synthetic mRNA encoding a target antigen, which is then encapsulated in a lipid nanoparticle (LNP) delivery system. Upon intramuscular injection, the LNPs are taken up by antigen-presenting cells, where the mRNA is translated into the target protein, which is then processed and presented to the immune system.

For PRRSV, experimental mRNA vaccines have been designed to encode the GP5 and M proteins, which form the major neutralizing epitope complex. Preclinical studies in pigs have demonstrated that mRNA-LNP vaccines induce robust neutralizing antibody responses and T-cell responses, including interferon-gamma producing cells. Importantly, these vaccines have shown efficacy against heterologous PRRSV-2 challenge, reducing viremia and lung pathology. The ability to rapidly update the mRNA sequence to match circulating strains offers a significant advantage over MLV vaccines, which require lengthy attenuation and safety testing.

Another experimental approach involves the use of lectin-based antiviral strategies. Griffithsin, a red algal lectin, has been shown to suppress PRRSV-2 replication in vitro and reduce early viremia in vivo [9]. Griffithsin binds to high-mannose glycans on the viral envelope glycoproteins, blocking viral entry. While not a vaccine, this approach could be used as a prophylactic or therapeutic adjunct to vaccination.

Diagnostic Workflow for Genomic Surveillance

The following Mermaid diagram illustrates a decision tree for the genomic surveillance of PRRSV in a diagnostic laboratory setting.

flowchart TD
    A[Clinical Sample: Serum, Lung, Oral Fluid], > B{RNA Extraction and RT-qPCR Screening}
    B, >|PRRSV Positive| C{Multiplex LNA RT-qPCR}
    B, >|PRRSV Negative| D[Report Negative / Test for Other Pathogens]
    C, >|PRRSV-1| E[ORF5 Sanger Sequencing]
    C, >|PRRSV-2| F{Lineage Identification}
    F, >|L8 Lineage| G[Targeted NGS Panel]
    F, >|Non-L8 Lineage| H[ORF5 Sanger Sequencing or WGS]
    E, > I[Phylogenetic Analysis and Lineage Assignment]
    G, > J[Whole-Genome Assembly and Recombination Detection]
    H, > I
    J, > K[Variant Tracking and Epidemiological Mapping]
    I, > K

The workflow begins with RNA extraction from clinical samples, followed by a screening RT-qPCR. Positive samples are then subjected to a multiplex LNA-based RT-qPCR for species and lineage differentiation [1]. Depending on the lineage identified, either Sanger sequencing of ORF5 or a targeted NGS panel for whole-genome sequencing is performed [8]. The resulting sequences are used for phylogenetic analysis, recombination detection, and epidemiological mapping.

Environmental and Management Factors

Environmental factors can influence the detection and transmission of PRRSV. The effect of temperature, relative humidity, and time on the detection of swine RNA viruses, including PRRSV, inoculated onto filter papers has been characterized [14]. Viral RNA stability was found to be inversely correlated with temperature and directly correlated with relative humidity. This information is critical for the design of environmental surveillance programs, such as those using barn manure pit samples. An exploratory pilot study investigating the potential relationship between PRRSV viremia changes and barn manure pit management procedures found that pit pumping events were associated with transient increases in PRRSV detection in air samples, suggesting a potential aerosolization risk [7].

Retrospective analysis of infectious agents in swine abortion materials has identified PRRSV as a major cause of reproductive failure [3]. Co-infections with other pathogens, such as Streptococcus suis, are common and can exacerbate clinical disease. The use of feed additives to modulate the gut microbiome and reduce clinical symptoms in PRRSV and S. suis co-infected pigs has been investigated, with some additives showing a reduction in nasal shedding of PRRSV [4].

Conclusion

Genomic surveillance of PRRSV is essential for understanding the evolutionary dynamics of this highly variable virus and for guiding control strategies. The development of multiplex LNA-based RT-qPCR assays and targeted NGS panels has significantly improved the ability to differentiate between PRRSV-1 and PRRSV-2 lineages and to detect emerging variants and recombinants. While MLV vaccines remain the cornerstone of PRRS control, their limitations in cross-protection and safety have spurred the development of next-generation vaccines, including mRNA-based platforms. Experimental mRNA vaccines have shown promise in inducing broad immune responses and protecting against heterologous challenge. Continued investment in genomic surveillance and vaccine innovation is critical for the eventual control and eradication of PRRS.

References

[1] Gyurján I, Sipos-Kozma Z, Ásványi B, et al. Development and validation of an LNA-based one-step multiplex RT-qPCR assay for differentiating Betaarterivirus europensis (PRRSV-1), Betaarterivirus americense (PRRSV-2), and the highly pathogenic L8 lineage of PRRSV-2. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42235629/

[2] Cotaquispe Nalvarte RY, Legua Barrios M, De la Cruz Vásquez E, et al. Genetic variability, N-glycosylation, and recombination in sublineage 1A of Betaarterivirus americense from commercial pig farms in Lima, 2019. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42232907/

[3] Bischoff H, Beumer M, Helmer C, et al. Retrospective analysis of infectious agents in swine abortion materials in the years 2021 to 2023. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42213157/

[4] Tran HT, Mercado AJ, Lahoti MM, et al. Effects of a novel feed additive on clinical symptoms and the nasal and cecal microbiome in nursery pigs challenged with PRRSV and Streptococcus suis. Transl Anim Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211862/

[5] Zhu Z, Lin Q, Zhang X, et al. PRRSV NSP2 hijacks host lipophagy via a LIPE-PNPLA2-AMPK-MTOR axis to promote viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42200529/

[6] Liu D, Yan Y, Fu X, et al. Porcine Reproductive and Respiratory Syndrome Virus NSP8 Suppresses NF-κB Signaling by Hijacking Host UBE2K and IKKα. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198770/

[7] Melini CM, Kikuti M, Yue X, et al. An Exploratory Pilot Study to Investigate the Potential Relationship Between Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Viremia Changes and Barn Manure Pit Management Procedures. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198580/

[8] Elshafie NO, Wilkes RP. Analytic and Diagnostic Validation of a Targeted Next-Generation Sequencing Panel for Common and Emerging Swine Respiratory Pathogens. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42197544/

[9] Kadekar D, Velayudhan D, Vinyeta E, et al. Lectin-Based Antiviral Strategies for Porcine Reproductive and Respiratory Syndrome Virus 2 Infection: Griffithsin Suppresses Viral Replication In Vitro and Reduces Early Viremia In Vivo. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42197483/

[10] Liu X, Hu Y, Zhou Q, et al. Heterodimerization of PRRSV replicase membrane proteins nsp2 and nsp3 regulates their cytoplasmic tail binding to viral RdRp domain for sgRNA synthesis. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42187313/

[11] Zhang X, Yao Y, Guo SY, et al. miR-378b-3p promotes porcine reproductive and respiratory syndrome virus replication by negatively regulating type I interferon expression via targeting OGT. J Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42187089/

[12] Wang A, Chen W, Wang B, et al. Myricetin activates innate antiviral immunity during PRRSV infection in MARC-145 cells. Vet Immunol Immunopathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42184610/

[13] Hassanien RT, Dittmar W, Balasuriya UBR, et al. Reverse genetics approach for arteriviruses using circular polymerase extension reaction. Access Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42181111/

[14] Armenta-Leyva B, Munguía-Ramírez B, Zhang Y, et al. Effect of temperature, relative humidity, and time on the detection of swine RNA viruses (PRRSV, PEDV, IAV) inoculated onto filter papers. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42180247/

[15] Ham S, Suh J, Na H, et al. Genetic and pathogenic characterization of a Korean NADC30-like PRRSV strain associated with high fever and mortality. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42172873/